ASM ASM International N.V.

ASMI Share Buyback Update August 24 – 28, 2020

ASMI Share Buyback Update August 24 – 28, 2020

Almere, The Netherlands

August 31, 2020, 5:45 p.m. CET

ASM International N.V. (Euronext Amsterdam: ASM) reports the following transactions, conducted under ASMI's current share buyback program.

DateRepurchased sharesAverage priceRepurchased value
August 24, 20205,000€ 127.65€ 638,250
August 25, 20201,500€ 127.65€ 191,475
August 26, 2020---
August 27, 20207,000€ 128.21€ 897,439
August 28, 20206,345€ 125.78€ 798,047
Total19,845€ 127.25€ 2,525,211

These repurchases were made as part of the €100 million share buyback program announced on June 2, 2020. Of the total program, 17.3% has been repurchased. For further details including individual transaction information please visit: .

About ASM International

ASM International NV, headquartered in Almere, the Netherlands, its subsidiaries and participations design and manufacture equipment and materials used to produce semiconductor devices. ASM International, its subsidiaries and participations provide production solutions for wafer processing (Front-end segment) as well as for assembly & packaging and surface mount technology (Back-end segment) through facilities in the United States, Europe, Japan and Asia. ASM International's common stock trades on the Euronext Amsterdam Stock Exchange (symbol ASM). For more information, visit ASMI's website at .

Cautionary Note Regarding Forward-Looking Statements: All matters discussed in this press release, except for any historical data, are forward-looking statements. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements. These include, but are not limited to, economic conditions and trends in the semiconductor industry generally and the timing of the industry cycles specifically, currency fluctuations, corporate transactions, financing and liquidity matters, the success of restructurings, the timing of significant orders, market acceptance of new products, competitive factors, litigation involving intellectual property, shareholders or other issues, commercial and economic disruption due to natural disasters, terrorist activity, armed conflict or political instability, changes in import/export regulations,  epidemics and other risks indicated in the Company's reports and financial statements. The Company assumes no obligation nor intends to update or revise any forward-looking statements to reflect future developments or circumstances.

This press release contains inside information within the meaning of Article 7(1) of the EU Market Abuse Regulation.

CONTACT

Investor and media contact:

Victor Bareño

T:

E:

Attachment

EN
31/08/2020

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on ASM International N.V.

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ASM International: 1Q24 results - better on all fronts. Heineken: Uphill from here. KPN: 1Q24 in line, guidance slightly increased on Youfone acquisition. Melexis: 1Q24 results in line a relief. Universal Music Group: Spotify 1Q24 Results and guidance beat on margins. Vopak: Good progress to start the year. Wereldhave: 1Q24 LFL slows sharply

Guy Sips ... (+4)
  • Guy Sips
  • Sharad Kumar S.P
  • Thibault Leneeuw
  • Wim Hoste
Martin Marandon-Carlhian ... (+2)
  • Martin Marandon-Carlhian
  • Stephane Houri

ASM International N.V : A very good Q1, outlook strengthened with GAA ...

>Q1 2024 results beat forecasts, due to a record gross margin link to a record contribution from China - Q1 2024 revenue was € 639m, up +2% q-o-q, but -8% y-o-y, above the consensus at € 628m. The gross margin was 52.9% well above the consensus at 48.4%. This improvement (vs Q4 2023 to 47.9%) principally stems from the mix and notably the contribution from China (a record level but not quantified). EBIT was € 192m (operating margin of 29.3%), i.e. 27% above the conse...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch